Cargando…

PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA

Detalles Bibliográficos
Autores principales: Djodikromo, Melissa, Bekker, Charlotte, Hermens, Rosella, Smit, Yolba, Govers, Tim, van den Bemt, Bart, Blijlevens, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430159/
http://dx.doi.org/10.1097/01.HS9.0000974728.72592.7a
_version_ 1785090889141452800
author Djodikromo, Melissa
Bekker, Charlotte
Hermens, Rosella
Smit, Yolba
Govers, Tim
van den Bemt, Bart
Blijlevens, Nicole
author_facet Djodikromo, Melissa
Bekker, Charlotte
Hermens, Rosella
Smit, Yolba
Govers, Tim
van den Bemt, Bart
Blijlevens, Nicole
author_sort Djodikromo, Melissa
collection PubMed
description
format Online
Article
Text
id pubmed-10430159
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104301592023-08-17 PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA Djodikromo, Melissa Bekker, Charlotte Hermens, Rosella Smit, Yolba Govers, Tim van den Bemt, Bart Blijlevens, Nicole Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430159/ http://dx.doi.org/10.1097/01.HS9.0000974728.72592.7a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Djodikromo, Melissa
Bekker, Charlotte
Hermens, Rosella
Smit, Yolba
Govers, Tim
van den Bemt, Bart
Blijlevens, Nicole
PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
title PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
title_full PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
title_fullStr PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
title_full_unstemmed PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
title_short PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
title_sort pb1978: patient-centredness is pivotal in a prospective dose reduction trial of tyrosine kinase inhibitors in patients with chronic myeloid leukaemia
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430159/
http://dx.doi.org/10.1097/01.HS9.0000974728.72592.7a
work_keys_str_mv AT djodikromomelissa pb1978patientcentrednessispivotalinaprospectivedosereductiontrialoftyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukaemia
AT bekkercharlotte pb1978patientcentrednessispivotalinaprospectivedosereductiontrialoftyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukaemia
AT hermensrosella pb1978patientcentrednessispivotalinaprospectivedosereductiontrialoftyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukaemia
AT smityolba pb1978patientcentrednessispivotalinaprospectivedosereductiontrialoftyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukaemia
AT goverstim pb1978patientcentrednessispivotalinaprospectivedosereductiontrialoftyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukaemia
AT vandenbemtbart pb1978patientcentrednessispivotalinaprospectivedosereductiontrialoftyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukaemia
AT blijlevensnicole pb1978patientcentrednessispivotalinaprospectivedosereductiontrialoftyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukaemia